These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17120130)

  • 1. Design and validation of a medication assessment tool for cancer pain management.
    Håkonsen GD; Hudson S; Loennechen T
    Pharm World Sci; 2006 Dec; 28(6):342-51. PubMed ID: 17120130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to medication guideline criteria in cancer pain management.
    Håkonsen GD; Strelec P; Campbell D; Hudson S; Loennechen T
    J Pain Symptom Manage; 2009 Jun; 37(6):1006-18. PubMed ID: 19500723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revision and validation of a medication assessment tool for chronic cancer pain management.
    Salmany SS; Koopmans SM; Treish IM; Jaber RE; Telfah S; Tuffaha HW
    Am J Hosp Palliat Care; 2012 Dec; 29(8):640-6. PubMed ID: 22310023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A medication assessment tool to evaluate prescribers' adherence to evidence-based guidelines in bipolar disorder.
    Al-Taweel DM; Alsuwaidan M
    Int J Clin Pharm; 2017 Aug; 39(4):897-905. PubMed ID: 28653259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.
    Kamyar M; Johnson BJ; McAnaw JJ; Lemmens-Gruber R; Hudson SA
    Pharm World Sci; 2008 Jan; 30(1):120-7. PubMed ID: 17721698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAT-CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community-acquired pneumonia.
    Høgli JU; Småbrekke L; Garcia BH
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):933-41. PubMed ID: 24797586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
    Garcia BH; Småbrekke L; Trovik T; Giverhaug T
    Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients.
    Fainsinger RL; Nekolaichuk CL; Lawlor PG; Neumann CM; Hanson J; Vigano A
    J Pain Symptom Manage; 2005 Mar; 29(3):224-37. PubMed ID: 15781173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The routine use of the Edmonton Classification System for Cancer Pain in an outpatient supportive care center.
    Arthur J; Yennurajalingam S; Nguyen L; Tanco K; Chisholm G; Hui D; Bruera E
    Palliat Support Care; 2015 Oct; 13(5):1185-92. PubMed ID: 25311930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A satisfaction survey on cancer pain management using a self-reporting pain assessment tool.
    Lim SN; Han HS; Lee KH; Lee SC; Kim J; Yun J; Park S; Park M; Choe Y; Ryoo HM; Lee K; Cho D; Zang DY; Choi J
    J Palliat Med; 2015 Mar; 18(3):225-31. PubMed ID: 25650504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of the pathophysiology and clinical characteristics of pain in a palliative medicine population.
    Gutgsell T; Walsh D; Zhukovsky DS; Gonzales F; Lagman R
    Am J Hosp Palliat Care; 2003; 20(2):140-8. PubMed ID: 12693647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers.
    Starrels JL; Peyser D; Haughton L; Fox A; Merlin JS; Arnsten JH; Cunningham CO
    Subst Abus; 2016; 37(1):148-53. PubMed ID: 26860130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids as co-analgesics with opioids for cancer pain: a survey of Australian and New Zealand palliative care clinicians.
    Eastman P; Le B
    Intern Med J; 2015 Dec; 45(12):1306-10. PubMed ID: 26444446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A medication assessment tool to evaluate adherence to medication guideline in asthmatic children.
    Liu HP; Chen HY; Johnson J; Lin YM
    Int J Clin Pharm; 2013 Apr; 35(2):289-95. PubMed ID: 23359031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain therapy in in-patients with cancer. Effects of a manual-based approach as guideline for pain-consulting service at a university hospital].
    Brinkers M; Pfau G; Lux A; Pfau G; Schneemilch C; Meyer F; Grond S
    Dtsch Med Wochenschr; 2016 Mar; 141(5):e39-46. PubMed ID: 26939109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations.
    Yamaguchi T; Shima Y; Morita T; Hosoya M; Matoba M;
    Jpn J Clin Oncol; 2013 Sep; 43(9):896-909. PubMed ID: 23885114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients.
    Webber K; Davies AN; Zeppetella G; Cowie MR
    J Pain Symptom Manage; 2014 Oct; 48(4):619-31. PubMed ID: 24766740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.